X5DNX5 (X5DNX5_HUMAN) Homo sapiens (Human)
Phosphodiesterase UniProtKBInterProInteractive Modelling
736 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: Q07343
It is possible new templates exist for this target since these models were created.
Available Structures
40 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of crosslink stabilized long-form PDE4B | homo-2-mer | 98.06 | 3×ZN; 2×NA; 2×MG; 2×IOD; | |||
| Crystal structure of crosslink stabilized long-form PDE4B in complex with (R)-(-)-rolipram | homo-2-mer | 98.05 | 3×ZN; 2×IOD; 2×ROL; 2×MG; | |||
| Crystal structure of human phosphodiesterase 4b with regulatory domain and d155988 | homo-2-mer | 100.0 | 2×ZN; 2×MG; 2×988; | |||
| Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with a Quinoline Inhibitor | homo-2-mer | 99.4 | 2×SK4; 2×ZN; 2×MG; 6×ARS; 4×GOL; | |||
| Catalytic domain of human phosphodiesterase 4B2B in complex with a tetrahydrobenzothiophene inhibit… | monomer | 99.72 | 1×ZN; 1×MG; 1×HBT; 1×GOL; | |||
| Crystal structure of phosphodiesterase 4B in complex with compound 31e | monomer | 100.0 | 1×NVW; 1×ZN; 1×CA; | |||
| Crystal structure of phosphodiesterase 4B in complex with compound 10f | monomer | 100.0 | 1×QPC; 1×ZN; 1×CA; | |||
| CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2B | monomer | 99.43 | 1×ZN; 1×MG; 3×ARS; | |||
| Selective Inhibition of the Catalytic Domain Of Human Phosphodiesterase 4B With A-33 | monomer | 100.0 | 1×19T; 1×MG; 1×ZN; 1×NA; 3×EDO; | |||
| PDE4 catalytic domain | monomer | 100.0 | 1×ZN; 1×MG; 1×NA; 1×2O5; 6×EDO; | |||
| Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R)-Mesopram | monomer | 100.0 | 1×ZN; 1×MG; 1×5RM; | |||
| Crystal structure of human PDE4b with 5-[3-[(1S,2S,4R)-Bicyclo[2.2.1]hept-2-yloxy]-4-methoxyp henyl… | monomer | 100 | 1×ZN; 1×0CP; 1×MG; | |||
| Crystal structure of PDE4B2B complexed with Rolipram (R & S) | monomer | 99.42 | 1×ZN; 1×MN; 1×ARS; 1×ROL; | |||
| CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH AMP | monomer | 99.41 | 2×ZN; 1×AMP; | |||
| CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH 8-Br-AMP | monomer | 99.41 | 2×ZN; 1×8BR; | |||
| Crystal structure of human phosphodiesterase 4B catalytic domain with inhibitor NPD-001 | monomer | 100 | 1×ZN; 1×MG; 3×ACT; 1×6M5; | |||
| Human phosphodiesterase 4B catalytic domain in complex with a pyrrolidinyl inhibitor. | monomer | 100 | 1×ZN; 1×MG; 1×9VE; | |||
| Catalytic domain of human phosphodiesterase 4B2B in complex with a quinoline inhibitor | monomer | 99.41 | 1×066; 1×ZN; 1×MG; 4×ARS; 3×GOL; | |||
| Crystal structure of PDE4B catalytic domain in complex with a pyrazolopyridine inhibitor | monomer | 99.41 | 1×ZN; 1×MG; 1×20A; 3×ARS; | |||
| PDE4B bound to MAPI compound 92a | monomer | 100 | 1×ZN; 1×MG; 1×VL9; | |||
| Catalytic domain of human phosphodiesterase 4b2b in complex with a 5-heterocycle pyrazolopyridine i… | monomer | 99.41 | 1×ZN; 1×MG; 3×ARS; 1×ZG2; 1×GOL; | |||
| Catalytic domain of human phosphodiesterase 4b2b in complex with a 5-heterocycle pyrazolopyridine i… | monomer | 99.4 | 1×ZN; 1×MG; 3×ARS; 1×ZG1; 2×GOL; | |||
| Crystal structure of PDE4B2B in complex with inhibitor NPV | monomer | 100 | 1×ZN; 2×MG; 1×NPV; | |||
| Catalytic Domain of Human Phosphodiesterase 4B in Complex with A Coumarin-Based Inhibitor | monomer | 100 | 1×Z72; 1×ZN; 1×MG; 1×SO4; | |||
| Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Roflumilast | monomer | 100 | 1×ZN; 1×MG; 1×ROF; | |||
| Crystal structure of human phosphodiesterase 4B (PDE4B) in complex with a [1,3,5]triazine derivative | monomer | 100 | 1×1S1; 1×MG; 1×ZN; 19×EDO; | |||
| Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Sildenafil | monomer | 100.0 | 1×ZN; 1×MG; 1×SO4; 1×VIA; | |||
| Human Phospodiesterase 4B in complex with pyridyloxy-benzoxaborole based inhibitor | monomer | 100 | 1×ZN; 1×MG; 1×6QQ; 17×EDO; | |||
| PDE4B In complex with ligand an2898 | monomer | 100 | 1×ZN; 1×MG; 1×3OJ; 14×EDO; | |||
| Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Filaminast | monomer | 100 | 1×ZN; 1×MG; 1×FIL; | |||
| Catalytic Domain Of Human Phosphodiesterase 4B In Complex With AMP | monomer | 100 | 1×ZN; 1×MG; 1×AMP; | |||
| Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Cilomilast | monomer | 100 | 1×ZN; 1×MG; 1×CIO; | |||
| Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R,S)-Rolipram | monomer | 100 | 1×ZN; 1×MG; 2×ROL; | |||
| Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Piclamilast | monomer | 100 | 1×ZN; 1×MG; 1×PIL; | |||
| Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Vardenafil | monomer | 100 | 1×ZN; 1×MG; 1×VDN; | |||
| Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R)-Rolipram | monomer | 100 | 1×ZN; 1×MG; 1×ROL; | |||
| Catalytic Domain Of Human Phosphodiesterase 4B In Complex With 1-(2-chloro-phenyl)-3,5-dimethyl-1H-… | monomer | 100 | 1×ZN; 1×MG; 1×6DE; | |||
| Catalytic Domain Of Human Phosphodiesterase 4B In Complex With 3,5-dimethyl-1-(3-nitro-phenyl)-1H-p… | monomer | 100 | 1×ZN; 1×MG; 1×7DE; | |||
| Crystal structure of N2 substituted pyrazolo pyrimidinones - a flipped binding mode in PDE5 | monomer | 100 | 1×ZN; 1×MG; 1×3P4; 1×MES; | |||
| Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN5004 | monomer | 100.0 | 2×ZN; 1×MG; 1×E31; 1×CL; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4wzi.1.A | homo-2-mer | 0.76 | 2×ZN; | 97.89 | ||